RxSight, Inc.RXSTNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P50
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-29.48%-73.6%
2024-16.98%+63.1%
2023-46.07%+60.9%
2022-117.90%+35.0%
2021-181.52%-182.9%
2020219.06%-96.2%
20195809.91%-